These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Do we still need distal protection in the treatment of SVG disease? Satler LF. Catheter Cardiovasc Interv; 2008 Nov 15; 72(6):804-5. PubMed ID: 19009627 [No Abstract] [Full Text] [Related]
5. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device. Grow P, Rab ST. Catheter Cardiovasc Interv; 2008 Nov 01; 72(5):636-40. PubMed ID: 18942125 [Abstract] [Full Text] [Related]
6. The MGuard stent: current promises and limitations. Kornowski R. Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):642-3. PubMed ID: 20333654 [No Abstract] [Full Text] [Related]
7. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial. Heuser RR. Catheter Cardiovasc Interv; 2011 Mar 01; 77(4):594. PubMed ID: 21351235 [No Abstract] [Full Text] [Related]
11. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts. Senter SR, Nathan S, Gupta A, Klein LW. J Invasive Cardiol; 2006 Feb 01; 18(2):49-53. PubMed ID: 16446515 [Abstract] [Full Text] [Related]
12. Tools & techniques: Percutaneous intervention of saphenous vein graft lesions. Agostoni P, Voskuil M, Onsea K, Vermeersch P, Stella PR. EuroIntervention; 2011 Nov 01; 7(7):878-9. PubMed ID: 22082583 [No Abstract] [Full Text] [Related]